Drug Search Results
More Filters [+]

IC-51

Alternative Names: ic-51, ic51, ic 51
Latest Update: 2016-06-02
Latest Update Note: Clinical Trial Update

Product Description

Japanese Encephalitis purified inactivated vaccine (Sourced from: https://clinicaltrials.gov/ct2/show/NCT00604708)

Mechanisms of Action: Vaccine

Novel Mechanism: No

Modality: Vaccine

Route of Administration: Intramuscular

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Intercell USA
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for IC-51

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Encephalitis, Japanese

Phase 3: Encephalitis, Japanese|Encephalitis, Viral|Encephalomyelitis|Healthy Volunteers

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

2006-7041-83/hah

N/A

Not yet recruiting

Diabetes Complications|Diabetes, Gestational|Pregnancy Outcomes

2021-12-14

ND01

N/A

Not yet recruiting

Tobacco Use Disorder

2019-09-02

2009-015595-10

P3

Completed

Encephalitis, Japanese

2013-08-09

IC51-322

P3

Completed

Encephalitis, Japanese

2013-08-01

Recent News Events

Date

Type

Title